tetano
Editor, Senior Moderator
Br J Biomed Sci
. 2025 May 27:82:14489.
doi: 10.3389/bjbs.2025.14489. eCollection 2025. Carotid Body Size on CT Angiography in Patients With COVID-19 Pneumonia
Kamber Goksu[SUP] 1 [/SUP], Ahmet Vural[SUP] 1 [/SUP], Ahmet Nedim Kahraman[SUP] 1 [/SUP]
Affiliations
Purpose: Many pathophysiological theories have been expressed regarding increased sympathetic activity along with respiratory failure in patients with COVID-19 pneumonia. In addition, the carotid bodies, which are directly related to increased blood oxygen levels and sympathetic activity, are known to be very rich in the angiotensin-converting enzyme 2 (ACE2) receptor, which the COVID-19 causative virus uses to enter the cell. Therefore, the probability of carotid bodies being affected in patients with COVID-19 pneumonia is quite high. Carotid bodies can be visualized with contrast-enhanced CT angiography (CTA), and we aimed to visualize possible carotid body enlargement in COVID-19 patients with CTA.
Methods: We retrospectively evaluated patients who were hospitalized for COVID-19 pneumonia during the pandemic in our hospital and who had CTA examinations at least 3 months after treatment. We drew a Region of Interest (ROI) from the periphery of both carotid bodies and measured the area from the widest part. Similarly, measurements were taken in the control group without a history of COVID-19, and the results of the two groups were compared statistically.
Results: We performed measurements on CTA images of 104 control subjects and 108 patients. The total carotid body area of the patients with COVID-19 pneumonia was 4.9 ± 3.7 mm[SUP]2[/SUP], and the carotid body area of the control group was 3.7 ± 2.4 mm[SUP]2[/SUP]. In comparing the two groups, the carotid body area was found to be statistically significantly larger (p < 0.05) in patients with COVID-19 pneumonia.
Conclusion: The size of the carotid body was found to be larger in patients with COVID-19 pneumonia compared to the control group. This finding may indicate conditions that lead to the activation of carotid body chemo and baroreceptors, such as increased sympathetic activity and a decrease in blood oxygen pressure in patients with COVID-19 pneumonia. Apart from this, it may also be possible for the carotid body to be directly infected with the virus. More specific studies that shed light on this aspect are needed.
Keywords: COVID-19; carotid body; computed tomography angiography; pneumonia; sympathetic nervous system.
. 2025 May 27:82:14489.
doi: 10.3389/bjbs.2025.14489. eCollection 2025. Carotid Body Size on CT Angiography in Patients With COVID-19 Pneumonia
Kamber Goksu[SUP] 1 [/SUP], Ahmet Vural[SUP] 1 [/SUP], Ahmet Nedim Kahraman[SUP] 1 [/SUP]
Affiliations
- PMID: 40496438
- PMCID: PMC12150061
- DOI: 10.3389/bjbs.2025.14489
Purpose: Many pathophysiological theories have been expressed regarding increased sympathetic activity along with respiratory failure in patients with COVID-19 pneumonia. In addition, the carotid bodies, which are directly related to increased blood oxygen levels and sympathetic activity, are known to be very rich in the angiotensin-converting enzyme 2 (ACE2) receptor, which the COVID-19 causative virus uses to enter the cell. Therefore, the probability of carotid bodies being affected in patients with COVID-19 pneumonia is quite high. Carotid bodies can be visualized with contrast-enhanced CT angiography (CTA), and we aimed to visualize possible carotid body enlargement in COVID-19 patients with CTA.
Methods: We retrospectively evaluated patients who were hospitalized for COVID-19 pneumonia during the pandemic in our hospital and who had CTA examinations at least 3 months after treatment. We drew a Region of Interest (ROI) from the periphery of both carotid bodies and measured the area from the widest part. Similarly, measurements were taken in the control group without a history of COVID-19, and the results of the two groups were compared statistically.
Results: We performed measurements on CTA images of 104 control subjects and 108 patients. The total carotid body area of the patients with COVID-19 pneumonia was 4.9 ± 3.7 mm[SUP]2[/SUP], and the carotid body area of the control group was 3.7 ± 2.4 mm[SUP]2[/SUP]. In comparing the two groups, the carotid body area was found to be statistically significantly larger (p < 0.05) in patients with COVID-19 pneumonia.
Conclusion: The size of the carotid body was found to be larger in patients with COVID-19 pneumonia compared to the control group. This finding may indicate conditions that lead to the activation of carotid body chemo and baroreceptors, such as increased sympathetic activity and a decrease in blood oxygen pressure in patients with COVID-19 pneumonia. Apart from this, it may also be possible for the carotid body to be directly infected with the virus. More specific studies that shed light on this aspect are needed.
Keywords: COVID-19; carotid body; computed tomography angiography; pneumonia; sympathetic nervous system.